Prescription Required
Inclusive of all taxes
In Prevention of Hepatitis A infection Hepatitis A is an inflammation of the liver caused by infection with the hepatitis A virus. Havrix 720 Junior Monodose Vaccine helps your body develop immunity by forming antibodies that your body needs for protection against hepatitis A virus. It is usually recommended for people who are at high risk of contracting hepatitis A. It is given by an injection into a muscle and should be administered at least 2 weeks prior to expected exposure.
It is not known whether it is safe to consume alcohol with Havrix 720 Junior Monodose Vaccine. Please consult your doctor.
Havrix 720 Junior Monodose Vaccine is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Havrix 720 Junior Monodose Vaccine is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Havrix 720 Junior Monodose Vaccine alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Havrix 720 Junior Monodose Vaccine is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Havrix 720 Junior Monodose Vaccine may not be needed in these patients. Please consult your doctor.
Havrix 720 Junior Monodose Vaccine is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Havrix 720 Junior Monodose Vaccine may not be needed in these patients. Please consult your doctor.
If you miss a dose of Havrix 720 Junior Monodose Vaccine, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More